Spots Global Cancer Trial Database for y90 ibritumomab tiuxetan
Every month we try and update this database with for y90 ibritumomab tiuxetan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma | NCT00722930 | Follicular Lymp... | Y90 Ibritumomab... | 18 Years - | Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas | |
| Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT | NCT02992223 | Refractory B-Ce... Recurrent B-Cel... | 19 Years - | Azienda Ospedaliera Città della Salute e della Scienza di Torino |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
